Important Update: While the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD remains the current global standard, a focused update to Chapter 3: Delaying CKD progression and managing its complications is currently underway to address emerging evidence on SGLT2 inhibitors, GLP-1-based therapies, and nonsteroidal mineralocorticoid receptor antagonists in people with CKD without diabetes.
The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease was published in March 2024 in Kidney International. Co-chaired by Adeera Levin, MD (Canada) and Paul Stevens, MB (United Kingdom), this update to the 2012 guideline provides actionable, evidence-based recommendations for healthcare professionals, patients, caregivers, and policymakers worldwide.
Key topics include CKD classification and risk assessment, management of complications, medication stewardship, and patient-centered care across diverse clinical settings.
Treatment approaches and actionable guideline recommendations are based on systematic reviews of the available evidence and developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. In addition to graded recommendations, the guideline includes Practice Points for areas where systematic reviews were not conducted, practical infographics, and a dedicated research agenda to guide future advances in CKD care.
KDIGO DIGITAL TOOLS
KDIGO 2024 CKD GUIDELINE VIDEOS
Top 10 Takeaways for Nephrologists
Primary Care in Chronic Kidney Disease: Insights from the KDIGO 2024 CKD Guideline
KDIGO 2024 Guideline for Chronic Kidney Disease: Key Messages for Primary Care Physicians
KDIGO 2024 Guideline for Chronic Kidney Disease: Key Messages for Primary Care Physicians
KDIGO Patient Experience Video with John Ortiz
KDIGO Presents: A CKD Patient Journey
KDIGO 2024 CKD GUIDELINE WEBINARS
Optimizing the Holistic Approach to the Evaluation and Management of CKD Five-Part Series
KDIGO 2024 CKD GUIDELINE SYNOPSIS
KDIGO 2024 CKD GUIDELINE COMMENTARIES
KDOQI
Key Takeaways for Nephrologists – Evaluation
Key Takeaways for Nephrologists – Management
KDIGO 2024 CKD Guideline Executive Summary
Sintesi delle Linee guida di pratica clinica KDIGO 2024 per la valutazione e la gestione della malattia renale cronica: conoscenze acquisite e incognite note
KDIGO 2024 CKD Guideline Key Takeaways for Nephrologists – Evaluation
I 10 punti chiave per i nefrologi sulla valutazione di persone con, o a rischio di, CKD secondo le Linee guida di pratica clinica KDIGO 2024 per la valutazione e gestione della malattia renale cronica
KDIGO 2024 CKD Guideline Key Takeaways for Nephrologists – Management
I 10 punti chiave per i nefrologi sulla gestione di persone con CKD secondo le Linee guida di pratica clinica KDIGO 2024 per la valutazione e la gestione della malattia renale cronica
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.
